Research
Get the latest news on ALS 
ALS SOD1 Trial: A 'Watershed Moment'
Human testing has begun of ISIS-SOD1-Rx, a compound designed to block production of a toxic protein in people with the SOD1-related form of familial (inherited) ALS
ALS TDI: Full Speed Ahead
ALS TDI's first-quarter 2010 research update can be summed up with one word: momentum.
MDA Awards $21 Million for Research
New MDA grants recently were approved for several forms of muscular dystrophy, ALS, Friedreich's ataxia, myasthenia gravis and other diseases in MDA's program.
Muscular Dystrophy Association Renews Partnership with ALS Therapy Development Institute to Develop New Treatments for Lou Gehrig's Disease
Buoyed by the extraordinary progress being made by the ALS Therapy Development Institute, the Muscular Dystrophy Association today announced a new milestone-driven grant of $2.5 million, adding to the $18 million MDA already has invested with ALS TDI - the world’s only non profit research center focused exclusively on developing treatments for amyotrophic lateral sclerosis (ALS).
